|
⚲
|
| Keyboard |
| Skyline Venture Management IV LLC
✚
|
|
|---|---|
| CIK # | 0001392103 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001392103] | |
| 4 | [0001392103] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Proteon Therapeutics Inc PRTO
Series A-1 Convertible Preferred Stock · derivative
|
2014-10-27 | Conversion | 2,341,664 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Series B Convertible Preferred Stock · derivative
|
2014-10-27 | Conversion | 2,173,913 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2014-10-27 | Sell | 56,038 | $10.00 | 560,380 |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2014-10-27 | Option exercise | 121,760 | $4.60 | 560,096 |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2014-10-27 | Conversion | 1,167,208 | ||
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2014-10-27 | Buy | 200,000 | $10.00 | 2,000,000 |
|
Proteon Therapeutics Inc PRTO
Warrants (Right to Buy) · derivative
|
2014-10-27 | Option exercise | 121,760 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Option (Right to Purchase) · derivative
|
2014-10-27 | Other | 1,389,064 | ||
|
Proteon Therapeutics Inc PRTO
Series D Convertible Preferred Stock · derivative
|
2014-10-27 | Conversion | 3,932,747 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Series C Convertible Preferred Stock · derivative
|
2014-10-27 | Conversion | 2,436,437 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Series A Convertible Preferred Stock · derivative
|
2014-10-27 | Conversion | 5,000,000 | $0.00 | |
|
Tetraphase Pharmaceuticals Inc TTPH
Common Stock
|
2014-03-12 | Other | 4,493 | $0.00 | |
|
Tetraphase Pharmaceuticals Inc TTPH
Common Stock
|
2014-03-12 | Other | 300,000 | $0.00 | |
|
Talphera Inc ACRX
Common Stock
|
2014-03-07 | Other | 1,300,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2014-02-20 | Conversion | 106,194 | ||
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2014-02-20 | Buy | 150,000 | $14.00 | 2,100,000 |
|
Concert Pharmaceuticals Inc CNCE
Series C Convertible Preferred Stock · derivative
|
2014-02-20 | Conversion | 600,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Series A Convertible Preferred Stock · derivative
|
2014-02-20 | Conversion | 2,200,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Series B Convertible Preferred Stock · derivative
|
2014-02-20 | Conversion | 3,000,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2014-02-20 | Conversion | 530,974 | ||
| showing 20 of 32 most recent transactions | |||||